NOVATO, Calif., June 27, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), today announced that it has ...

Ultragenyx Pharmaceuticals' GTX-102 earns FDA Breakthrough status after early data shows sustained progress in Angelman syndrome patients.

Both TEGSEDI and WAYLIVRA are legacy assets that were originally brought to the EU market via an Ionis subsidiary, Akcea ...

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is one of the 10 best healthcare penny stocks to buy according to analysts. On June ...

Other companies working on antisense treatments for Angelman syndrome include Ultragenyx, which reported positive phase 1/2 results with its GTX-102 drug earlier this year, and Roche/Genentech ...

Financial giant UBS has declared that enough is enough with lagging healthcare valuations – and now believes it will be the ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

This first phase marks a major milestone in the transformation of Canary Wharf into one of the most digitally advanced commercial districts in the world. Completed installations include a suite of ...

Dead butt syndrome occurs when the gluteus medius stops firing due to unuse or sitting all day. Here are 5 exercises to help activate your glutes right now.